BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3984570)

  • 21. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study.
    Fauvet R; Poncelet C; Boccara J; Descamps P; Fondrinier E; Daraï E
    Fertil Steril; 2005 Feb; 83(2):284-90; quiz 525-6. PubMed ID: 15705364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
    Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
    Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of fertility preserving operations in malignant ovarian tumors].
    Kleine W
    Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.
    Tan Y; Sinniah R; Bay BH; Singh G
    J Pathol; 1999 Sep; 189(1):60-5. PubMed ID: 10451489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
    Marcickiewicz J; Brännström M
    Acta Obstet Gynecol Scand; 2006; 85(12):1496-500. PubMed ID: 17260228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Borderline tumor of the ovary. II. Pathology, treatment and prognosis].
    Lundvall L
    Ugeskr Laeger; 1987 Nov; 149(49):3313-7. PubMed ID: 3328358
    [No Abstract]   [Full Text] [Related]  

  • 28. [Conservative operations in malignant I-stage ovarian tumors].
    Mar'ina LA
    Vopr Onkol; 1978; 24(3):64-8. PubMed ID: 206020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI appearances of borderline ovarian tumours.
    Bent CL; Sahdev A; Rockall AG; Singh N; Sohaib SA; Reznek RH
    Clin Radiol; 2009 Apr; 64(4):430-8. PubMed ID: 19264189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
    Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S
    Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
    Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
    J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence and prognostic factors in borderline ovarian tumors.
    Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
    Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of patients with marginal tumors of the ovary].
    Vinokurov VL
    Vopr Onkol; 1989; 35(7):870-4. PubMed ID: 2773407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
    Wen YH; Yee H; Goswami S; Shukla PS
    Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian mucinous cystadenoma.
    Piatkowski Z; Sikorowa L; Tarlowska L
    Pol Med J; 1972; 11(1):143-6. PubMed ID: 5040989
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tumor degeneration of an autogenous ovarian transplant].
    Hamann M; Lindemann G; Albrecht G; Zipprich KW
    Zentralbl Gynakol; 1985; 107(21):1323-5. PubMed ID: 4082820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
    Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
    Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Borderline mixed epithelial tumor of the ovary].
    Osadchaia VV
    Arkh Patol; 1980; 42(10):56-8. PubMed ID: 7447744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy and course in 105 borderline tumors of the ovary].
    Wienold J; Sarembe B; Richter P
    Zentralbl Gynakol; 1989; 111(11):721-7. PubMed ID: 2781885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.